LFCR logo

Lifecore Biomedical, Inc.

LFCR
Healthcare|Drug Manufacturers - Specialty & Generic|US
$6.36
-0.04 (-0.63%)
Cash / Share
$0.61

About

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

Stock Price

-3.9%(1Y)
1M
-1.1%
3M
+26.9%
6M
+32.8%
YTD
-22.2%
1Y
-12.8%
3Y
-12.0%
5Y
-35.2%

Pipeline Summary

0 total trials
0
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4

Key Facts

Market Cap$241.1M
Employees406 (-23% YoY)
CEOPaul Josephs
IPO DateFeb 15, 1996
Beta0.99
52-Week Range$3.63 – $8.98
Avg Volume330,207
ExchangeNASDAQ

Ownership

Float90.4%
Shares Outstanding37.9M

Recent Insider Trades

Kiper Christopher SAWARD
Jun 4, 202625,907 shares
OBUS NELSONAWARD
Jun 4, 202625,907 shares
Aryeh JasonAWARD
Jun 4, 202625,907 shares
Schechter JoshuaAWARD
Jun 4, 202625,907 shares
Korenberg Matthew EAWARD
Jun 4, 202625,907 shares

Peers

ACBAurora Cannabis Inc.
$344.5M
ACHVAchieve Life Sciences, Inc.
$691.5M
BIOABioAge Labs Inc.
$201.0M
CGCCanopy Growth Corporation
$275.8M
CVRXCVRx, Inc.
$23.1M
IMMPImmutep Limited
$24.6M
OMIOwens & Minor, Inc.
$207.1M
PRQRProQR Therapeutics N.V.
$190.5M
Data last updated: Nov 9, 2026, 04:19 AM